Mars Boosts Investment in U.S. Operations
Mars, the famous maker of M&M’s and Skittles, has announced plans to invest an additional $2 billion in its domestic operations by the end of 2026. The aim is to develop a more “resilient” U.S. business model.
This new investment includes a $240 million natural bakery facility set to open in Salt Lake City, Utah, soon. The huge facility, featuring over 339,000 square feet of space, is expected to generate more than 230 jobs and produce around 1 billion bars annually.
“The U.S. is our largest and most vital market,” stated Mars CFO Claus Aagaard, emphasizing its significance for long-term growth. He added that it’s not just about expanding their legacy manufacturing but also about strategic acquisitions in the natural bakery sector.
Historical Commitment to Manufacturing
The announcement builds on over $6 billion that Mars has invested in U.S. production over the last five years. Earlier this year, the company also opened a $450 million facility in Lewisburg, Ohio, which created up to 270 new jobs for its Royal Canin Dry Pet Food brand.
Notably, around 94% of Mars products sold domestically are produced within the U.S.
This trend follows a growing list of companies enhancing their investments in U.S. manufacturing, aligning with the Trump administration’s goals of revitalizing domestic production and reducing reliance on imports.
Many firms from various sectors, including tech, pharmaceuticals, and automotive, started announcing these investments during the early part of President Trump’s second term. Some experts consider this push for domestic manufacturing a valuable goal but also acknowledge the challenges involved in bringing back jobs quickly and seamlessly.
Major Industry Investments
Besides Mars, other companies are also making significant commitments. For instance, Hyundai recently dedicated $20 billion to expand manufacturing in the U.S., while General Motors plans to invest $4 billion over the next two years to increase gas and electric vehicle production.
Additionally, Eli Lilly is set to invest $27 billion to bolster domestic drug production, raising its total U.S. manufacturing investment to over $500 billion since 2020.
In February, Apple announced a historic $500 billion investment plan aimed at U.S. manufacturing and innovation. This includes building an advanced AI server facility near Houston and doubling its Advanced Manufacturing Fund to $10 billion.
Experts like Santo suggest that establishing factories, particularly in high-tech industries, can take years and involve considerable costs. He noted that while the U.S. currently faces some staffing challenges, its vast energy resources and advances in automation may help mitigate these issues in the long run.
